SMTL ID : 8vyf.1

SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement

Coordinates
PDB Format
Method
ELECTRON MICROSCOPY
Oligo State
hetero-1-1-1-1-1-mer
Ligands
1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Magaret, C.A. et al., Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features. Nat Commun (2024)
Release Date
2024-03-27
Peptides
Spike glycoprotein: A
S2L20 Heavy Chain: B
S2L20 Light Chain: C
S2X303 Heavy Chain: D
S2X303 Light Chain: E
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C
D
H
E
L

Spike glycoprotein

S2L20 Heavy Chain

S2L20 Light Chain

S2X303 Heavy Chain

S2X303 Light Chain

Related Entries With Identical Sequence

7so9.1 | 7soa.1 | 7sod.1 | 7soe.1 | 7sof.1 | 7tlz.1 | 7tm0.1 | 8gtq.1 | 8vye.1 | 8vyg.1